Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus

Korean Journal of Laboratory Medicine

Volumn 30, Issue 1, 2010, Pages 38-44

  Woo, Kwang Sook ^a   Kim, Kyung Eun ^a   Kim, Jeong Man ^a   Han, Jin Yeong ^a   Chung, Won Tae ^a   Kim, Kyeong Hee ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77954854613     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.1.38     Document Type: Article

References (28)

1. Sammaritano LR, Gharavi AE, Lockshin MD. Antiphospholipid antibody syndrome: immunologic and clinical aspects. Semin Arthritis Rheum 1990;20:81-96.
2. Love PE and Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
3. Uthman I, Godeau B, Taher A, Khamashta M. The hematologic manifestations of the antiphospholipid syndrome. Blood Rev 2008;22: 187-94.
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
5. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-32.
6. Galli M and Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol 2003;16:211-25.
7. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002;29:2531-6.
8. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S, et al. Antibodies to beta 2-glycoprotein and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1466-74.
9. Sahin M, Duzgun N, Tunc SE, Tutkak H. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Clin Biochem 2007;40:526-30.
10. Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 2005;52:2774-82.
11. Lee SS, Cho ML, Joo YS, Kim WU, Hong YS, Min JK, et al. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol 2001; 28:520-4.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A, et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ann Rheum Dis 1994;53:140-2.
14. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:145-51.
15. Danowski A, Kickler TS, Petri M. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006;33:1775-9.
16. Mok MY, Chan EY, Fong DY, Leung KF, Wong WS, Lau CS. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol 2005; 32:622-8.
17. Lee SG, Cha HS, Yang YS. The association of HLA-DRB1 and DQB1 alleles and a study of anticardiolipin antibody and anti-beta2 glycoprotein I antibody in Korean SLE patients. Immune Netw 2002;2: 227-32.
18. Swadzba J, Iwaniec T, Szczeklik A, Musial J. Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. J Thromb Haemost 2007;5:1883-9.
19. Scientific and Standardization Committee. Lupus AntiCoagulant/Phospholipid-dependent antibodies. Annual Report. Boston: International Society for Thrombosis and Haemostasis, 2002.
20. Obermoser G, Bitterlich W, Kunz F, Sepp NT. Clinical significance of anticardiolipin and anti-β2-glycoprotein I antibodies. Int Arch Allergy Immunol 2004;135:148-53.
21. Nash MJ, Camilleri RS, Kunka S, Mackie IJ, Machin SJ, Cohen H. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004;2:1077-81.
22. Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, et al. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Lupus 2007;16:810-6.
23. Arvieux J, Roussel B, Jacob MC, Colomb MG. Measurement of antiphospholipid antibodies by ELISA using b2-glycoprotein I as an antigen. J Immunol Methods 1991;143: 223-9.
24. Lee EY, Lee CK, Lee TH, Chung SM, Kim SH, Cho YS, et al. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res 2003;111:29-32.
25. Ebeling F, Pettersson T, Muukkonen L, Vahtera E, Rasi V. Beta-2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab Invest 2003;63:111-8.
26. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood1994;84:4203-8.
27. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019-27.
28. Kim TM, Kim JS, Han SW, Hong YS, Kim I, Ha J, et al. Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res 2009;123:436-43.